This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Janssen Research & Development, LLC.
Reference
Schain F, et al. Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease. European Journal of Health Economics : 4 Dec 2020. Available from: URL: https://doi.org/10.1007/s10198-020-01249-x
Rights and permissions
About this article
Cite this article
Chronic graft-versus-host disease substantial economic burden in Sweden. PharmacoEcon Outcomes News 868, 8 (2020). https://doi.org/10.1007/s40274-020-7340-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7340-1